Macitentan Interactions
There are 210 drugs known to interact with macitentan, along with 3 disease interactions. Of the total drug interactions, 49 are major, 158 are moderate, and 3 are minor.
- View all 210 medications that may interact with macitentan
- View macitentan disease interactions (3)
Most frequently checked interactions
View interaction reports for macitentan and the medicines listed below.
- Activated Charcoal (charcoal)
- Adcirca (tadalafil)
- Advair Diskus (fluticasone / salmeterol)
- Aldactone (spironolactone)
- Amaryl (glimepiride)
- Anoro Ellipta (umeclidinium / vilanterol)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- AquADEKs (multivitamin with minerals)
- Aralast (alpha 1-proteinase inhibitor)
- Atrovent (ipratropium)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Breo Ellipta (fluticasone / vilanterol)
- Crestor (rosuvastatin)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Iron Sulfate (ferrous sulfate)
- Klonopin (clonazepam)
- Lasix (furosemide)
- Levothyrox (levothyroxine)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Uptravi (selexipag)
- Valium (diazepam)
- Victoza (liraglutide)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
Macitentan disease interactions
There are 3 disease interactions with macitentan which include:
Report options
QR code containing a link to this page
More about macitentan
- macitentan consumer information
- Compare alternatives
- Reviews (11)
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
